About Lamivudine And Zidovudine Tablets IP
Lamivudine and Zidovudine Tablets IP is a popular combination antiretroviral medication designed for exceptional efficacy in managing HIV-1 infection. Powered by pharmaceutical grade Lamivudine (150 mg) and Zidovudine (300 mg), these splendid white to off-white, film-coated tablets are conveniently administered orally. Each batch is manufactured in India at stellar WHO-GMP, ISO certified plants and securely packaged in HDPE bottles or blister packs. With a stellar shelf life of up to three years, it ensures consistent, reliable therapy. Consult your physician due to possible drug interactions and contraindications. Reserve your supply now and experience marked improvements in patient outcomes!
Advantage, Plant Application, and Used By
Lamivudine and Zidovudine Tablets IP deliver a stellar advantage by combining two NRTIs, enhancing HIV-1 treatment effectiveness and reducing resistance risk. Manufactured in ISO and WHO-GMP certified plants, this exceptional therapy suits global healthcare applications. Widely used by adults and adolescents under prescription, it is trusted by healthcare professionals worldwide for its splendid efficacy and safety standards.
Sample Availability, Supply Ability, and Dispatch
Lamivudine and Zidovudine Tablets IP samples are available for genuine inquiries, allowing evaluation before placing bulk orders. Our supply ability is robust, ensuring prompt and consistent dispatching even for larger orders. Sale price is offered at a competitive markdown, factoring in quantity. FOB Port options are flexible, supporting seamless export and global distribution. A nominal charge may apply for sample provision.
FAQ's of Lamivudine And Zidovudine Tablets IP:
Q: How should Lamivudine and Zidovudine Tablets IP be taken for optimal results?
A: The tablets are administered orally, typically as prescribed by your healthcare provider, and are best taken at the same times each day to maintain consistent drug levels.
Q: What are the primary benefits of using this NRTI combination therapy?
A: This therapy offers exceptional viral suppression, reduces HIV resistance development, and is trusted for its splendid safety profile and efficacy in adults and adolescents.
Q: When is this medicine contraindicated for HIV patients?
A: Lamivudine and Zidovudine Tablets IP should not be used in individuals with known hypersensitivity to either ingredient or any other component of the formulation.
Q: Where is this medicine manufactured and what are its regulatory approvals?
A: The medicine is manufactured in India at WHO-GMP and ISO certified facilities, assuring international quality and regulatory compliance.
Q: What adverse effects might occur during usage?
A: Possible adverse effects include headache, nausea, fatigue, anaemia, and neutropenia. It's important to consult your healthcare provider if any side effects appear.